Frontiers in Pharmacology | Drugs Outcomes Research and Policies

Original Research

Published on 02 Feb 2023

Long-term comparative effectiveness and safety of dabigatran, rivaroxaban, apixaban and edoxaban in patients with atrial fibrillation: A nationwide cohort study

in Drugs Outcomes Research and Policies

Maxim Grymonprez
Tine L. De Backer
Xander Bertels
Stephane Steurbaut
Lies Lahousse

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1125576

24,837 views
21 citations

Original Research

Published on 02 Feb 2023

Potentially clinically significant drug-drug interactions in older patients admitted to the hospital: A cross-sectional study

in Drugs Outcomes Research and Policies

Zuzana Očovská
Martina Maříková
Jiří Vlček

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1088900

6,635 views
12 citations

Clinical Trial

Published on 01 Feb 2023

14-day pantoprazole- and amoxicillin-containing high-dose dual therapy for Helicobacter pylori eradication in elderly patients: A prospective, randomized controlled trial

in Drugs Outcomes Research and Policies

Qinyu Yang
Cong He
Yi Hu
Junbo Hong
Zhenhua Zhu
Yong Xie
Xu Shu
Nonghua Lu
Yin Zhu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1096103

36,001 views
10 citations

Original Research

Published on 30 Jan 2023

A pharmacist-led medication review service with a deprescribing focus guided by implementation science

in Drugs Outcomes Research and Policies

Nada Alaa Eddine
James Schreiber
Ahmed F. El-Yazbi
Haya Shmaytilli
Mohamed Ezzat Khamis Amin

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1097238

6,238 views
3 citations

Policy and Practice Reviews

Published on 26 Jan 2023

Orphan drugs’ clinical uncertainty and prices: Addressing allocative and technical inefficiencies in orphan drug reimbursement

in Drugs Outcomes Research and Policies

Hans-Georg Eichler
Michael Kossmeier
Markus Zeitlinger
Brigitte Schwarzer-Daum

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1074512

7,090 views
8 citations

Original Research

Published on 26 Jan 2023

Immune checkpoint inhibitor-induced aplastic anaemia: Case series and large-scale pharmacovigilance analysis

in Drugs Outcomes Research and Policies

Qian Guo
Jin Ning Zhao
Ting Liu
Jian Gao
Hui Guo
Jing Min Cheng

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1057134

6,134 views
4 citations

Systematic Review

Published on 25 Jan 2023

The effect of antibiotics on the periodontal treatment of diabetic patients with periodontitis: A systematic review and meta-analysis

in Drugs Outcomes Research and Policies

Ziwei Tang
Qi Fan
Qingsong Jiang
Xiaolong Li
Yan Wang
Hu Long
Wenli Lai
Fan Jian

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1013958

4,929 views
7 citations

Review

Published on 23 Jan 2023

Bibliometric analysis and evidence of clinical efficacy and safety of digital pills

in Drugs Outcomes Research and Policies

Olena Litvinova
Elisabeth Klager
Andy Wai Kan Yeung
Nikolay T. Tzvetkov
Oliver Kimberger
Maria Kletecka-Pulker
Harald Willschke
Atanas G. Atanasov

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1023250

6,315 views
4 citations

Systematic Review

Published on 20 Jan 2023

A systematic review and Bayesian meta-analysis of the antibiotic treatment courses in AECOPD

in Drugs Outcomes Research and Policies

Haichuan Yu
Ting Lei
Xiaojie Su
Lu Zhang
Zhouzhou Feng
Xinlong Chen
Jian Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1024807

3,277 views
6 citations

Opinion

Published on 20 Jan 2023

Rational use of drugs for the elderly during the COVID-19 pandemic in China: Challenges and opportunities

in Drugs Outcomes Research and Policies

Qingqing Yin
Dandan Feng
Yong Zhao
Xiaojuan Zhu
Yan Dong
Jianchun Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1106144

1,460 views
1 citation

Systematic Review

Published on 20 Jan 2023

Regional risk of tuberculosis and viral hepatitis with tumor necrosis factor-alpha inhibitor treatment: A systematic review

in Drugs Outcomes Research and Policies

Nina Jahnich
Peter D. Arkwright

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1046306

3,021 views
9 citations

Original Research

Published on 16 Jan 2023

Analysis of spontaneous reports of suspected adverse reactions after vaccination against COVID-19 in Slovakia

in Drugs Outcomes Research and Policies

Monika Lassanova
Stefan Lassan
Silvia Liskova
Tomas Tesar
Monika Cicova

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1097890

3,706 views
3 citations

Original Research

Published on 13 Jan 2023

Adverse drug reactions in an ageing PopulaTion (ADAPT) study: Prevalence and risk factors associated with adverse drug reaction-related hospital admissions in older patients

in Drugs Outcomes Research and Policies

Caitriona Cahir
Carmel Curran
Caroline Walsh
Anne Hickey
Ross Brannigan
Ciara Kirke
David J. Williams
Kathleen Bennett

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1029067

8,420 views
24 citations

Perspective

Published on 12 Jan 2023

Advancing evidence-based treatment of infectious diseases in children with real-world data: Opportunities and challenges

in Drugs Outcomes Research and Policies

Kendra K. Radtke
Atul J. Butte

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1054688

2,278 views
1 citation

Original Research

Published on 12 Jan 2023

Treatment attrition rates and relevant risk factors in multiple myeloma: A real-world study in China

in Drugs Outcomes Research and Policies

Wenjiao Tang
Jinrong Yang
Yan Li
Li Zhang
He Li
Jie Wang
Yi Liao
Chunlan Zhang
Ying Qu
Yuhuan Zheng

Frontiers in Pharmacology

doi 10.3389/fphar.2023.979111

3,948 views
5 citations

Correction

Published on 11 Jan 2023

Corrigendum: Formulation and development of transferrin targeted solid lipid nanoparticles for breast cancer therapy

in Drugs Outcomes Research and Policies

Geeta S. Bhagwat
Rajani B. Athawale
Rajeev P. Gude
Shadab Md
Nabil A. Alhakamy
Usama A. Fahmy
Prashant Kesharwani

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1123542

1,231 views